Product Details
| Product Name:
BM-131246 |
CAS No.:
103787-97-9 |
| Purity:
100.00% |
Supply Ability:
10g |
| Release date:
2026/04/21 |
Product Introduction
Bioactivity
| Name | BM-131246 |
| Description | BM-131246 is an orally available and antidiabetic active thiazolidinedione derivative for the study of diabetes. |
| In vivo | After repeated oral doses, BM-131246 attains approximately proportional increases in plasma levels in ob/ob mice. The terminal half-life for BM-131246 is about 4 h[1], and it is quickly absorbed into the bloodstream. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Shipping with blue ice/Shipping at ambient temperature. |
| Keywords | BM-131246 | BM131246 | BM 131246 |
| Inhibitors Related | Insulin (human) | Indirubin Derivative E804 | Semaglutide | Morin | Ornithine-α-ketoglutarate | (2S,3R,4S)-4-Hydroxyisoleucine | Picropodophyllin | Sorbic acid | Brigatinib | L-Cysteine hydrochloride hydrate | Tranexamic acid | Linsitinib |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
$29.00
|
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-07-14 |
|
|
|
|
Anhui Zhongda Biotechnology Co., Ltd
|
2023-11-03 |
|
|
$1800.00
|
VIP2Y
|
TargetMol Chemicals Inc.
|
2025-07-25 |
United States